STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Monday reported a loss of $1 million in its third quarter.

The Stamford, Connecticut-based company said it had a loss of 2 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.

The biotechnology company posted revenue of $20.3 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $15.7 million.

Cara shares have risen 14% since the beginning of the year. In the final minutes of trading on Monday, shares hit $17.20, a rise of 23% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News